Review identifies long non-coding RNA as crucial prognostic biomarkers for hepatocellular carcinoma, suggesting potential for improved patient outcomes.
Key Points
Long non-coding RNA biomarkers can improve prognosis prediction in hepatocellular carcinoma patients, potentially enhancing survival rates.
Evidence shows that alterations in expression levels of lncRNAs correlate with the progression of hepatocellular carcinoma and patient outcomes.
This review focuses on the validation of lncRNA biomarkers, either singularly or in combinations, as independent prognostic indicators in HCC.
Understanding the roles of oncogenes and tumor suppressor genes regulated by lncRNAs could lead to better therapeutic strategies for HCC.